Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair.

Exploring the lasting legacy of the STS/ACC TVT Registry
"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry. "This is not a trial; this is real-world experience."
Advanced risk score predicts long-term survival after mitral valve surgery
The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.
Can IVL help cardiologists treat mitral valve disease?
Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification.
Pascal system from Edwards Lifesciences linked to key benefits after M-TEER, T-TEER
The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.

Joan Michaels, RN, director of the American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR) Transcatheter Valve Therapies (TVT) and IMPACT congenital heart registries, explains how TVT has helped reshape cardiology and the heart team approach.

Exploring the lasting legacy of the STS/ACC TVT Registry

"We're constantly trying to keep our fingers on the pulse of what's happening in the real world," explained Joan Michaels, RN, director of the STS/ACC TVT Registry. "This is not a trial; this is real-world experience."

Advanced risk score predicts long-term survival after mitral valve surgery

The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.

Video interview with Jaffar Khan, MD, St. Francis Heart Center, explaining tests using IVL in mitral annular calcification (MAC).

Can IVL help cardiologists treat mitral valve disease?

Jaffar Khan, MD, explained his team's work using intravascular lithotripsy balloons in a cadaver heart to break up mitral annular calcification.

PASCAL Precision transcatheter valve repair system

Pascal system from Edwards Lifesciences linked to key benefits after M-TEER, T-TEER

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.

Statue of Liberty New York City healthcare

Late-breaking clinical trials announced for New York Valves 2025

The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.

‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind

A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not include animal tissue.

Vinay Badhwar, MD, and his team perform a robotic TAVR explant and aortic valve replacement. Image courtesy of WVU Medicine.

Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement

The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.